Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Psilocybin's effect on human brain synaptic plasticity.Translational psychiatry · 2026-07-15Multi-metric evaluations of acute psychedelic effects on fMRI brain entropy.Nature communications · 2026-06-24Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-29The Psychological Support Model in Psilocybin Research: Psychotherapy in Disguise?Psychiatric Research and Clinical Practice · 2026-03-01Concomitant use of antidepressants and classic psychedelics: A scoping review.Journal of psychopharmacology (Oxford, England) · 2025-10-01A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01Validation of the Danish Translation of the Revised Mystical Experience Questionnaire (MEQ30) and Possible Impact of Setting, Dose and Intention.Journal of psychoactive drugs · 2025-01-01Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01Altered states of consciousness in Danish healthy volunteers and recreational users of psilocybin and the possible impact of setting and intention: Danish validation of the five-dimensional altered states of consciousness questionnaire.Journal of psychopharmacology (Oxford, England) · 2024-10-01Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humansmedRxiv · 2024-09-22Single-Dose Psilocybin Therapy for Alcohol Use Disorder: Pharmacokinetics, Feasibility, Safety, and Efficacy in an Open-Label StudyResearch Square · 2024-08-23Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patientsNeuroscience Applied · 2024-01-01CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity.Headache · 2024-01-01Amygdala response to emotional faces following acute administration of psilocybin in healthy individuals.Neuroscience applied · 2024-01-01Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.Neuroscience applied · 2024-01-01The therapeutic potential of psychedelics: the European regulatory perspectiveThe Lancet · 2023-02-10Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation.Comprehensive psychoneuroendocrinology · 2023-02-01Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labellingNeuroscience Applied · 2023-01-01A multi-metric evaluation of psilocybin effects on functional brain entropy in healthy volunteersNeuroscience Applied · 2023-01-01Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effectsNeuroImage · 2022-12-01Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial).BMJ open · 2022-10-14Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivitymedRxiv · 2022-07-10Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humansNeuroscience Applied · 2022-01-01Acute change in functional brain entropy following psilocybin administration in healthy volunteersNeuroscience Applied · 2022-01-01Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.Journal of psychopharmacology (Oxford, England) · 2022-01-01Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report.Frontiers in pharmacology · 2022-01-01Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals.Frontiers in psychology · 2022-01-01Music programming for psilocybin-assisted therapy: Guided Imagery and Music-informed perspectives.Frontiers in psychology · 2022-01-01Psilocybin modulation of dynamic functional connectivity is associated with plasma psilocin and subjective effectsmedRxiv · 2021-12-17A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive EffectsPsyArXiv · 2021-12-14A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive EffectsPsyArXiv · 2021-12-14P.0593 Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individualsEuropean Neuropsychopharmacology · 2021-12-01P.0828 Psilocybin enhances emotional response to music in healthy individualsEuropean Neuropsychopharmacology · 2021-12-01Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experienceEuropean Neuropsychopharmacology · 2021-09-01Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans.Journal of psychopharmacology (Oxford, England) · 2021-04-01Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experiencebioRxiv · 2021-02-05Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individualsbioRxiv · 2021-01-29P.227 Psilocybin induces resting-state functional connectivity changes, which correlate with plasma psilocin levels and psychedelic experienceEuropean Neuropsychopharmacology · 2020-11-01A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2020-04-01P.188 Long-term effects of psilocybin on cerebral serotonin 2A receptor levels and personalityEuropean Neuropsychopharmacology · 2019-12-01P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levelsEuropean Neuropsychopharmacology · 2019-12-01Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levelsNeuropsychopharmacology · 2019-06-01Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levelsNeuropsychopharmacology · 2019-06-01Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study.Human brain mapping · 2019-05-01Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humansEuropean Neuropsychopharmacology · 2019-01-01